EXENATIDE

Clinical Indication

Type 2 diabetes

Comments

Once a week preparation (Bydureon®) is formulary. Conditional on prescriber being trained to select and train patients. Use in conjunction with Updated Nice Clinical Guideline.

————————-

Twice daily preparation (Byetta®) is non formulary. However, existing  patients may remain on treatment

Date of classification

June 2015

Review date

June 2015

Green CONDITIONAL

Drugs for which GPs are able to take full responsibility for prescribing and monitoring subject to specified conditions e.g. prescribing in line with agreed LMSG guidance or able to demonstrate suitable competence see comments under individual entries.